FDA Adverse Event Injury Summary report: N

PLM A+ PLANTINUM MOD

MDR report key: 1622259 · Received March 2, 2010

Report

Report Number
2921482-2010-00098
Event Type
Injury
Date Received
March 2, 2010
Date of Event
December 25, 2009
Report Date
February 2, 2010
Manufacturer
HOSPIRA, INC.
Product Code
FRN
PMA / PMN Number
K070398
Removal / Correction Number
NA
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
RISK MANAGER

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE WAS NOT ISOLATED OR IDENTIFIED BY SERIAL NUMBER; THEREFORE, IT WILL NOT BE RETURNED FOR INVESTIGATION.

Description of Event or Problem · 1

THE CUSTOMER CONTACT REPORTED THAT THE PATIENT RECEIVED MORE MEDICATION THAN INTENDED. THE PATIENT WAS BEING TREATED IN THE INTERMEDIATE CARE UNIT FOR A DIAGNOSIS OF PAROXYSMAL SUPRA-VENTRICULAR TACHYCARDIA, CORONARY ARTERY DISEASE AND HYPERTENSION. ON (B) (6) 2009 AT 2345, THE DEVICE WAS PROGRAMMED IN THE DOSE CALCULATION MODE TO DELIVER HEPARIN 25,000 UNITS/250ML, WITH A DOSE OF 1000 UNITS/HR, AND A VTBI (VOLUME TO BE INFUSED) OF 200ML, AT A CALCULATED RATE OF 10ML/HR AND THE DELIVERY WAS STARTED. ON (B) (6) 2009 AT 0230, THE DEVICE SOUNDED AN UNSPECIFIED ALARM. AT THIS TIME, THE NURSE NOTED THE HEPARIN CONTAINER WAS EMPTY. THE PHYSICIAN WAS NOTIFIED AND ORDERED A PTT (PARTIAL THROMBOPLASTIN TIME) LEVEL BE DRAWN. THE RESULT WAS REPORTED AS >200 SECONDS. THE HEPARIN THERAPY WAS DISCONTINUED. NO FURTHER TREATMENT WAS REQUIRED. THE DEVICE WAS REMOVED FROM CLINICAL SERVICE. AT 2305, THE HEPARIN THERAPY WAS RESUMED USING A REPLACEMENT DEVICE. THE PATIENT WAS DISCHARGED ON (B) (6) 2009. ALTHOUGH REQUESTED, NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 PLM A+ PLANTINUM MOD 80FRN FRN HOSPIRA, INC. NA NA

Patients

Seq Age Sex Outcome Treatment
1 86 YR Required Intervention HEPARIN, LIST 07793, LOT UNK, MFR BY HOSPIRA, INC| PLUM A+ SOFTWARE MODULE, LIST #12097, SN UNK